V2-0477.cs.json

FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)

{
  "resourceType": "CodeSystem",
  "id": "v2-0477",
  "meta": {
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"
    ]
  },
  "text": {
    "status": "additional",
    "div": "<div>!-- Snipped for Brevity --></div>"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-oid",
      "valueUri": "urn:oid:2.16.840.1.133883.18.304"
    }
  ],
  "url": "http://hl7.org/fhir/v2/0477",
  "version": "2.8.2",
  "name": "v2 Controlled Substance Schedule",
  "status": "active",
  "experimental": true,
  "publisher": "HL7, Inc",
  "contact": [
    {
      "telecom": [
        {
          "system": "other",
          "value": "http://hl7.org"
        }
      ]
    }
  ],
  "description": "FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)",
  "caseSensitive": false,
  "valueSet": "http://hl7.org/fhir/ValueSet/v2-0477",
  "content": "complete",
  "concept": [
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
          "valueString": "Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision."
        }
      ],
      "code": "I",
      "display": "Schedule I"
    },
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
          "valueString": "Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability."
        }
      ],
      "code": "II",
      "display": "Schedule II"
    },
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
          "valueString": "Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States."
        }
      ],
      "code": "III",
      "display": "Schedule III"
    },
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
          "valueString": "Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States."
        }
      ],
      "code": "IV",
      "display": "Schedule IV"
    },
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
          "valueString": "Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States."
        }
      ],
      "code": "V",
      "display": "Schedule V"
    },
    {
      "extension": [
        {
          "url": "http://hl7.org/fhir/StructureDefinition/valueset-comments",
          "valueString": "State defined"
        }
      ],
      "code": "VI",
      "display": "Schedule VI"
    }
  ]
}